At a
March 25 session at the Keystone Symposia's HIV Vaccines conference, Brenchley presented new data from a study of
pigtail macaques chronically infected with the highly pathogenic SIVmac239 strain that suggests probiotics in combination with antiretroviral therapy (ARVs) enhance mucosal immunity and could possibly improve the long - term prognosis of people with HIV.